Harvard Bioscience, Inc. (HBIO) Financials

HBIO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 137.4 million 64.3 million
2023-09-30 139.7 million 65.4 million
2023-06-30 142.9 million 67.5 million
2023-03-31 145.6 million 71.2 million

HBIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 3.2 million 1.4 million
2023-09-30 4.0 million 1.4 million
2023-06-30 2.9 million 1.1 million
2023-03-31 1.6 million 1.2 million

HBIO Net Income

No data available :(

HBIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 4.3 million - 6.2 million
2023-09-30 5.3 million - 6.5 million
2023-06-30 4.3 million 38.2 million 6.8 million
2023-03-31 3.8 million - 7.1 million

HBIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 42.7 million
2023-09-30 42.7 million
2023-06-30 42.4 million
2023-03-31 42.8 million

HBIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.1 million 3.2 million 5.3 million 6.2 million
2023-09-30 401000 2.8 million 5.8 million 5.7 million
2023-06-30 625000 3.0 million 5.4 million 6.2 million
2023-03-31 224000 2.9 million 6.3 million 6.0 million

HBIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 28.2 million 13.2 million
2023-09-30 25.4 million 10.6 million
2023-06-30 28.8 million 12.1 million
2023-03-31 30.0 million 11.6 million

HBIO

Price: $3.85

52 week price:
3.44
6.29

Earnings Per Share: -0.08 USD

P/E Ratio: -59.13

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 13674

Ebitda: 836000

Market Capitalization: 167.2 million

Links: